Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
Version 2 2021-04-19, 09:47
Version 1 2021-04-13, 14:59
media
posted on 2021-04-19, 09:47 authored by Adis Journals on behalf of, Debdulal Chakraborty, Michael W. Stewart, Jay U. Sheth, Tushar K. Sinha, Subhendu Boral, Arnab Das, Soumen Mondal, Angshuman MukherjeeArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
